Europe – Implications of coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials

Par
RIS.WORLD
-
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
  • Points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials
  • Overview of comments received on ‘Points to consider on implications of Coronavirus
    disease 5 (COVID-19) on methodological aspects of ongoing clinical trials (EMA/158330/2020)
  • Draft responses to stakeholder comments on the Points to consider on the impact of COVID-19 on methodological aspects of ongoing clinical trials..

ARTICLES CONNEXESPLUS DE L'AUTEUR